Streetbeat News

Price Targets

EXAI

Berenberg analyst Gaurav Goparaju has initiated coverage on Exscientia (NASDAQ:EXAI) with a Buy rating and a price target of $13.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:15 am

MORF

Berenberg analyst Gaurav Goparaju has initiated coverage on Morphic Holding (NASDAQ:MORF) with a Buy rating and a price target of $75.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:14 am

PPBT

JonesTrading analyst Catherine Novack has initiated coverage on Purple Biotech (NASDAQ:PPBT) with a Buy rating and a price target of $8.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:13 am

VET

Canaccord Genuity analyst Mike Mueller has initiated coverage on Vermilion Energy with a Buy rating and a price target of C$24.5.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:11 am

TSX:TOU

Canaccord Genuity analyst Mike Mueller has initiated coverage on Tourmaline Oil with a Buy rating and a price target of C$75.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:10 am

TSX:CPG

Canaccord Genuity analyst Mike Mueller has initiated coverage on Crescent Point Energy (TSX:CPG) with a Buy rating and a price target of C$12.5.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:09 am

BTE

Canaccord Genuity analyst Anthony Petrucci has initiated coverage on Baytex Energy with a Buy rating and a price target of C$6.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:08 am

TSX:ARX

Canaccord Genuity analyst Mike Mueller has initiated coverage on ARC Resources with a Buy rating and a price target of C$22.5.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:07 am

TVTX

JP Morgan analyst Anupam Rama has initiated coverage on Travere Therapeutics (NASDAQ:TVTX) with an Overweight rating and a price target of $26.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:01 am

DFS

Piper Sandler analyst Kevin Barker has downgraded Discover Financial Services (NYSE:DFS) from Overweight to Neutral and lowered the price target from $130 to $112.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:00 am